p53 is activated in response to disruption of the pre-mRNA splicing machinery.
about
Modification by ubiquitin-like proteins: significance in apoptosis and autophagy pathwaysModulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response.MicroRNA-34a modulates MDM4 expression via a target site in the open reading framePRPF8 defects cause missplicing in myeloid malignancies.Variants affecting exon skipping contribute to complex traits.Molecular bioelectricity: how endogenous voltage potentials control cell behavior and instruct pattern regulation in vivo.Detained introns are a novel, widespread class of post-transcriptionally spliced introns.ROS and p53 in regulation of UVB-induced HDM2 alternative splicingAlternative splicing of NUMB, APP and VEGFA as the features of pancreatic ductal carcinoma.Quantitative proteomic analyses of mammary organoids reveals distinct signatures after exposure to environmental chemicals.Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma.Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machineryOncogenic alternative splicing switches: role in cancer progression and prospects for therapy.Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs.The development and application of small molecule modulators of SF3b as therapeutic agents for cancer.A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 PathwayA small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX proteinDysregulation of cotranscriptional alternative splicing underlies CHARGE syndrome.Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity.Inhibition of Casein Kinase 2 Protects Oligodendrocytes From Excitotoxicity by Attenuating JNK/p53 Signaling Cascade
P2860
Q27011543-AD0426F6-22FE-4F9E-A7C7-0F02DA3600FCQ30561763-94A76CD6-2F6A-4536-AB32-8755B204CADBQ34369223-FD0C3A66-0235-4186-8F52-F903020F1170Q34429362-EF6440F1-458A-4DD1-95D6-C0C306277D28Q34469030-DA535F34-FE13-497C-A0E4-2E481990C0C8Q34572217-A32042E1-A98F-4238-8227-95C6D88A4CB3Q34799985-5B0D8E2A-A367-45DA-84A2-833CC6A73CD9Q34807527-D1B8335E-931F-4EFF-9EDA-A0BCE4329710Q35742205-587FE38B-F8F8-44AC-B6F3-7937117680F7Q36684669-31B6A3BB-E988-455C-AEAA-FC2FA8436455Q37162388-24810BAE-3A90-44F0-8674-91687AA6B031Q37185632-0BB45622-2727-4472-B25D-32194589C0B7Q37304724-AA8D045D-19D7-49AD-8766-638C38CFB8CCQ37511674-157DAD83-F7EB-4C47-B672-F974B6013B2BQ38033985-FCF1BCCB-6884-4FF4-8B00-2C48A14E80F2Q40291299-B7E17819-DE9E-4426-86C2-2DC9A91C0719Q40516887-8FB7D011-AA69-4787-9D3B-B7059917F72CQ41632623-B15E53D4-437F-4F1B-9077-BFC67B5CC349Q42369637-3C53F66D-EFFD-40C7-8410-6DC7F583FA79Q47222829-F10FBABC-A632-43C8-B575-BC8E5CDD82CBQ55137359-4DADEC29-4D8B-40FD-9EC5-F8C8D15B6AC0Q57110813-4B19E9AA-C716-42CD-840A-DF1E273138F4
P2860
p53 is activated in response to disruption of the pre-mRNA splicing machinery.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
p53 is activated in response to disruption of the pre-mRNA splicing machinery.
@en
p53 is activated in response to disruption of the pre-mRNA splicing machinery.
@nl
type
label
p53 is activated in response to disruption of the pre-mRNA splicing machinery.
@en
p53 is activated in response to disruption of the pre-mRNA splicing machinery.
@nl
prefLabel
p53 is activated in response to disruption of the pre-mRNA splicing machinery.
@en
p53 is activated in response to disruption of the pre-mRNA splicing machinery.
@nl
P2093
P2860
P356
P1433
P1476
p53 is activated in response to disruption of the pre-mRNA splicing machinery
@en
P2093
P2860
P2888
P356
10.1038/ONC.2012.38
P407
P577
2012-02-20T00:00:00Z